|
Epidemiology: Osteo & Rheumatoid Arthritis - Defining the patient populationsPublished by: Datamonitor Published: Oct. 15, 2003 - 40 Pages Table of ContentsTABLE OF CONTENTS EXECUTIVE SUMMARY 4 Introduction 4 Scope and coverage of the Brief 4 Key findings about OA and RA Epidemiology 5 OSTEOARTHRITIS 8 Key studies and reviews 8 Limitations, assumptions and caveats 16 OA patient population 18 RHEUMATOID ARTHRITIS 25 Key studies and reviews 25 Limitations, assumptions and caveats 30 RA patient population 32 APPENDIX 39 Bibliography 39 AbstractIntroductionDiseases associated with an aging population, such as arthritis, have received substantial attention from both the media and pharmaceutical companies in recent years. However, despite the impact of the diseases themselves, estimates of the number of patients suffering from OA and RA vary widely, creating difficulty for pharmaceutical and device companies looking to size the potential market. Scope * Evaluates key studies and data points pertinent to the OA and RA population * Provides Datamonitor estimates of the OA population by age, and RA population by age and sex, in the seven major markets * Estimates of knee and hip OA in the seven major markets for companies marketing products for these specific joints * 2010 forecasted OA and RA populations for sales potential evaluation of products in development Report Highlights With an OA patient potential across the seven major markets forecast to reach over 80 million by 2010, companies with PCP sales capabilities cannot ignore the revenue opportunity this high-volume, chronic, market offers. The size of the global RA patient population is overestimated by most sources, as significant differences exist between countries, so companies should be cautious in their revenue projections when entering new markets outside the US, particularly Japan. Reasons to Purchase * Benchmark your arthritis portfolio against other disease areas by fully understanding the size of the populations * Focus your marketing message through identification of the unique demographics of the OA and RA patient groups * Improve forecasting with better comprehension of the factors that will change the patient potential to the end of the decade Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||